Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2017Blood AdvancesOpen Access

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSpero R. CatalandThe Ohio State University Wexner Medical CenterPKPeter J. KourlasColumbus Oncology and Hematology AssociatesSYShangbin YangBeijing University of Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cataland et al. (2017) studied this question.

synapsesocial.com/papers/6a870d04a810ea404bcfa1f0https://doi.org/10.1182/bloodadvances.2017009308
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relapse of Thrombotic Thrombocytopenic Purpura: Is It a Continuum of Disease?2005 · 48 citations
  2. 2Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion1996 · 792 citations
  3. 3Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis1996 · 904 citations
  4. 4Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome1991 · 868 citations
  5. 5Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura2008 · 33 citations